News Image

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros’ Director Nominees

Provided By GlobeNewswire

Last update: May 27, 2025

Keros Board Best Equipped to Oversee Strategic Review Process and Execute on Ultimate Outcome of that Process

ADAR1’s Disruptive and Self-Serving Campaign Stands to Jeopardize the Future Value Maximizing Potential of the Company

Read more at globenewswire.com

KEROS THERAPEUTICS INC

NASDAQ:KROS (7/18/2025, 8:00:02 PM)

After market: 13.75 0 (0%)

13.75

-0.61 (-4.25%)



Find more stocks in the Stock Screener

Follow ChartMill for more